SomnoMed (ASX:SOM) Insider Ownership: 0.00 % (As of Sep. 02, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASX:SOM SomnoMed Ltd ASX:SOM
41 GF Score
Price A$0.36
GF Value A$0.42
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is SomnoMed Insider Ownership?

SomnoMed ASX:SOM +5.97% 41 Insider Ownership is 0.00 % as of Sep. 02, 2026. GuruFocus rates ASX:SOM with a GF Score™ of 41/100 and a GF Value™ of A$0.42 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, SomnoMed's insider ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, SomnoMed's Institutional Ownership is 10.09%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, SomnoMed's Float Percentage Of Total Shares Outstanding is 0.00%.

SomnoMed Insider Ownership Historical Data

* Premium members only.

The historical data trend for SomnoMed's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SomnoMed Insider Ownership Chart

SomnoMed Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25 Jun26
Insider Ownership
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

SomnoMed Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Insider Ownership Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
ASX:SOM
41GF Score
SomnoMed Ltd ASX:SOM
Insider Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SomnoMed Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

Frequently Asked Questions Learn more about Insider Ownership →
What does a Insider Ownership of 0.00 % mean?
SomnoMed (ASX:SOM) has a Insider Ownership of 0.00 % as of Sep. 02, 2026. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on SomnoMed and its competitors.
Is SomnoMed's Insider Ownership too high?
SomnoMed's current Insider Ownership is 0.00 %. Overall, SomnoMed has a GF Score™ of 41/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does SomnoMed's Insider Ownership compare to ABT and SYK?
SomnoMed's Insider Ownership of 0.00 % can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Insider Ownership for a Medical Devices & Instruments company?
A good Insider Ownership depends on the Medical Devices & Instruments industry context. However, Insider Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Insider Ownership mean?
A high Insider Ownership can signal that a stock is expensive relative to its fundamentals. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on SomnoMed and its competitors. SomnoMed's current Insider Ownership is 0.00 %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SomnoMed stock overvalued right now?
Based on GuruFocus' analysis, SomnoMed (ASX:SOM) is currently considered Modestly Undervalued. The stock's GF Value™ is A$0.42, compared to a current price of A$0.36 — trading 15.5% below its estimated fair value. The current Insider Ownership is 0.00 %. SomnoMed's overall GF Score™ is 41/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Insider Ownership calculated?
Insider Ownership is calculated from a company's financial statements. For SomnoMed (ASX:SOM), the current Insider Ownership is 0.00 % as of Sep. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is SomnoMed (ASX:SOM) Overvalued in 2026?

Based on GuruFocus' analysis, SomnoMed stock appears to be undervalued. The current stock price of A$0.36 is trading 15.5% below its estimated GF Value™ of A$0.42. GuruFocus considers SomnoMed to be Modestly Undervalued.

Key valuation signals for ASX:SOM:

  • Insider Ownership: 0.00 %
  • GF Value™: A$0.42 vs. price of A$0.36 (15.5% below fair value)
  • GF Score™: 41/100 with 3 warning signs

No single metric tells the full story. See the ASX:SOM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

SomnoMed Business Description

Other Exchanges SOMNF:USARJV:Germany
Address 20 Clarke Street, Level 3, Crows Nest, Sydney, NSW, AUS, 2065
SomnoMed Ltd provides treatment solutions for sleep-related breathing disorders, including obstructive sleep apnea, snoring, and bruxism. It is engaged in commercializing SomnoDent Mandibular Advancement Splint (MAS) and other oral devices for sleep-related disorders in Australia and overseas. The other products in the company's portfolio include SomMorning Repositioner; SomnoBrux splint, a custom-fit, acrylic splint (dental guard) for upper teeth designed to protect teeth from grinding and scraping during Bruxism; and SomTabs cleaning tablets that have been developed to clean oral appliances. Geographically, the company generates maximum revenue from Europe, followed by North America and the Asia Pacific region.
41GF Score

Get the complete analysis for ASX:SOM

Insider Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.36
Price
A$0.42
GF Value